Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis
Observational
OA: closed
CC0
⤵ 117 in-corpus citations
AI-generated summary
This study analyzed the distribution of estrogen and progesterone receptor isoforms in uteri with and without adenomyosis across the menstrual cycle.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To test the hypothesis that the expression of the different isoforms of the estrogen receptor alpha (ER-α) and beta (ER-β) and the progesterone receptor A (PR-A) and B (PR-B) would be differentially modulated in uteri with adenomyosis compared with controls and that modulation would be related to the menstrual cycle.
DESIGN: Case control, blinded comparison.
SETTING: University department.
PATIENT(S): 54 premenopausal women with and 35 without uterine adenomyosis as the sole pathology.
INTERVENTION(S): Multiple samples studied using immunohistochemistry for estrogen and progesterone receptors.
MAIN OUTCOME MEASURE(S): Histomorphometric analysis of receptor expression.
RESULT(S): The ER-α expression in the adenomyotic endometrium was different from that of the normal endometrium and the foci in the midsecretory phase of the cycle, but expression of ER-α in the inner and outer myometrium was not statistically significantly different. The ER-β expression was statistically significantly elevated in the adenomyotic functionalis gland during the proliferative phase and throughout the myometrium across the entire menstrual cycle. Expression of PR-A was similar to that of PR-B, with reduced expression in the basalis stroma, and inner and outer myometrium in the adenomyotic samples. The pattern of ER-β, PR-A, and PR-B expression was similar in the endometrial basalis and adenomyotic foci.
CONCLUSION(S): These data suggest ER-β expression and the lack of PR expression are related to the development and/or progression of adenomyosis and might explain the poor response of adenomyosis-associated menstrual symptoms to progestational agents.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (60)
- Adenomyosis: current perspectives via openalex
- Adenomyosis uteri: an update via openalex
- Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis via openalex
- Dating the Endometrial Biopsy via openalex
- Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis via openalex
- Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy via openalex
- Endometriosis: a dysfunction and disease of the archimetra via openalex
- Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women via openalex
- Insertion of mirena after endometrial resection in patients with adenomyosis via openalex
- Intact progesterone receptors are essential to counteract the proliferative effect of estradiol in a genetically engineered mouse model of endometriosis via openalex
- Neonatal administration of tamoxifen causes disruption of myometrial development but not adenomyosis in the C57/BL6J mouse via openalex
- Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium via openalex
- Phenotypic characterisation of the inner and outer myometrium in normal and adenomyotic uteri via openalex
- Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent via openalex
- Surgical and medical treatment of adenomyosis via openalex
- Treatment of endometriosis with estrogen-progestin combination and progestogens alone via openalex
- W2016344930 via openalex
- W2017110402 via openalex
- W2028950695 via openalex
- W2033232788 via openalex
- W2033945601 via openalex
- W2034864360 via openalex
- W2065088050 via openalex
- W2065955514 via openalex
- W2079078286 via openalex
- W2110922412 via openalex
- W2121201031 via openalex
- W2121475182 via openalex
- W2122148434 via openalex
- W2124561299 via openalex
- W2127954353 via openalex
- W2137852967 via openalex
- W2141269411 via openalex
- W2150003940 via openalex
- W2151274670 via openalex
- W2155274896 via openalex
- W2160027012 via openalex
- W2160756193 via openalex
- W2166188229 via openalex
- W2166673284 via openalex
- W2394566517 via openalex
- W2396340237 via openalex
- W6609642172 via openalex
- W6641683417 via openalex
- W6684733989 via openalex
- W1579407907 via openalex
- W1749510241 via openalex
- W1907234242 via openalex
- W1927161069 via openalex
- W1965397941 via openalex
- W1966488185 via openalex
- W1968277161 via openalex
- W1970917001 via openalex
- W1971324961 via openalex
- W1988649251 via openalex
- W1994523467 via openalex
- W1999415440 via openalex
- W2004270170 via openalex
- W2007283211 via openalex
- W2012994584 via openalex
Cited by (50)
- Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
- Adenomyosis and fertility: from pathophysiology to optimizing reproductive outcomes 2026
- Progesterone receptor expression is selectively reduced in adenomyosis among endometriosis-associated lesions: a cross-sectional immunohistochemical study of 118 specimens from 100 women 2026
- Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot study 2026
- Role of oral gonadotropin-releasing hormone antagonists in the management of uterine adenomyosis: a narrative review 2026
- Tissue-predominant estrogen metabolic remodeling in adenomyosis revealed by LC-MS/MS profiling 2026
- Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review 2025
- Characteristics of factors contributing to disorders of reproductive function in patients with adenomyosis 2025
- Adenomyosis’ association with low progesterone yet increased interleukin-6, vascular endothelial growth factor and cyclooxygenase-2 2025
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Molecular Basis of Impaired Decidualization in the Eutopic Endometrium of Endometriosis Patients 2025
- Mutation profile and chromosomal abnormality in adenomyosis 2025
- Impaired fertility in adenomyosis: a murine model reveals endometrial receptivity and progesterone resistance imbalances 2024
- Overview of crosstalk between stromal and epithelial cells in the pathogenesis of adenomyosis and shared features with deep endometriotic nodules 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Exploring the Endocrine Mechanisms in Adenomyosis: From Pathogenesis to Therapies 2024
- Additional file 2 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- Retrospective Study on the Incidence of Benign, Premalignant, and Malignant Gynecologic Disorders in Patients with Adenomyosis: Analysis of 5648 Specimens 2024
- Biological characteristics related to treatment effects of the levonorgestrel-releasing intrauterine system on adenomyosis-associated dysmenorrhoea 2024
- Additional file 2 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- Additional file 1 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- Additional file 1 of Improvement of early miscarriage rates in women with adenomyosis via oxytocin receptor antagonist during frozen embryo transfer-a propensity score-matched study 2024
- The effect of hormone-modulating therapy during pregravid preparation on the course of pregnancy and childbirth in patients with a history of endometriosis 2023
- Quand intervenir en cas d'endométriose avant AMP ? 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions 2023
- Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review 2023
- The effect of hormone-modulating therapy during pregravid preparation on the course of pregnancy and childbirth in patients with a history of endometriosis 2023
- The "freeze-all" strategy seems to improve the chances of birth in adenomyosis-affected women 2023
- Exosomes: potential diagnostic markers and drug carriers for adenomyosis 2023
- Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy 2022
- Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development 2022
- Characteristics of endometrial hormonal homeostasis and receptor apparatus in women with adenomyosus who had papillary thyroid carcinoma 2022
- Endometrial receptivity in adenomyosis and the role of signaling pathways in the pathogenesis of the disease (literature review) 2022
- Neonatal feeding of an estrogen receptor β agonist induces external adenomyosis-like lesions in ICR mouse 2022
- Immunohistochemical expression of Drosha is reduced in eutopic and ectopic endometrium of women with adenomyosis 2022
- Expressão das proteínas reguladoras da biogênese dos miRNAs em lesões de adenomiose 2022
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility 2022
- Mechanism Study of Cinnamomi Ramulus and Paris polyphylla Sm. Drug Pair in the Treatment of Adenomyosis by Network Pharmacology and Experimental Validation 2022
- Insights on Adenomyosis Development 2022
- Uterine bleeding: how understanding endometrial physiology underpins menstrual health 2022
- There is no significant correlation of adenomyosis with benign, premalignant and malignant gynecological pathologies. Retrospective study on 647 specimens 2022
- Progesterone Actions and Resistance in Gynecological Disorders 2022
- Neonatal feeding of an estrogen receptor β agonist induces external adenomyosis-like lesions in ICR mouse 2022
- Mechanisms and Pathogenesis of Adenomyosis 2022
- Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists 2021
- Molecular Mechanisms of Endometrial Functioning in Women with Polycystic Ovary Syndrome 2021
- The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis 2021
- Clinical outcomes after single-versus double-embryo transfers in women with adenomyosis: a retrospective study 2021
- [Adenomyosis pathophysiology: An unresolved enigma] 2021
Source provenance
- europepmc
- last seen: 2026-10-23T06:08:06.940705+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:08:47.456808+00:00
License: CC0
· commercial use OK